It is a pharma private limited company based in Bhiwandi, Maharashtra, India, established in 2018.
2018 | Bhiwandi, Maharashtra, India | ActiveScutonix Lifesciences Private Limited, a active private limited company, was established on 31 October 2018 in Bhiwandi, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999MH2018PTC316606. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Employing 18 professional, Its leadership includes Ashwin Mohanbhai Desai (Director), Harshadkumar Shamjibhai Patel (Director), Sanjaykumar Ranachhodbhai Thumar (Director). It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No-1440/4B, Bldg Bf, Gala 111, 1St Flr, Kalher Rajlaxmi Comm Complex, Bhiwandi, Bhiwandi, Maharashtra, 421302.
U74999MH2018PTC316606
316606
31 October 2018
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Scutonix Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashwin Mohanbhai Desai | Director | 11 Dec 2018 | Current |
| Harshadkumar Shamjibhai Patel | Director | 11 Dec 2018 | Current |
| Sanjaykumar Ranachhodbhai Thumar | Director | 11 Dec 2018 | Current |
| Gaurang Ramnikbhai Kakadiya | Director | 11 Dec 2018 | Current |
| Rakesh Kumar Ravji Khoont | Director | 31 Oct 2018 | Current |
| Dineshbhai Nagajibhai Hadiya | Additional Director | 27 Oct 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Scutonix Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 60.2% decrease. The company also saw a substantial fall in profitability, with a 1807.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 131.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Scutonix Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 May 2022 | Others | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Scutonix Lifesciences has a workforce of 18 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Scutonix Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scutonix Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Scutonix Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Scutonix Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Dineshbhai Nagajibhai Hadiya was appointed as a Additional Director was appointed as a Additional Director on 27 Oct 2022 & has been associated with this company since 3 years 2 months . was documented.
Progress on A charge with Others amounted to Rs. 10.00 M with Charge ID 100597522 was registered on 25 May 2022. was documented.
The activity Ashwin Mohanbhai Desai was appointed as a Director was appointed as a Director on 11 Dec 2018 & has been associated with this company since 7 years 1 month . was completed.
Harshadkumar Shamjibhai Patel was appointed as a Director was appointed as a Director on 11 Dec 2018 & has been associated with this company since 7 years 1 month . was recorded as a recent event.
The CIN of Scutonix Lifesciences Private Limited is U74999MH2018PTC316606.
Scutonix Lifesciences Private Limited is headquartered at H.No-1440/4B, Bldg Bf, Gala 111, 1St Flr, Kalher Rajlaxmi Comm Complex, Bhiwandi, Bhiwandi, Maharashtra, 421302.
Scutonix Lifesciences Private Limited was incorporated on 31 October 2018.
The current directors of Scutonix Lifesciences Private Limited are
The primary industry of Scutonix Lifesciences Private Limited is Manufacturing.
Scutonix Lifesciences Private Limited is unlisted.
The authorized capital of Scutonix Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX